Elsewhere on HealthThreads: Sleep apnea | Erectile dysfunction | Asthma | Prostate cancer | Heart disease | Weight loss | Rheumatoid arthritis | Cholesterol | Pancreatic cancer |
Tue, Jan 26 | from Kansas City infoZine
The U.S. Food and Drug Administration approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults.
Good news for diabetics. A Patna doctor has helped develop Liraglutide, a new anti-diabetic drug, which got the approval of the Food and Drug Administration in the US for clinical use on Tuesday.
Wed, Jan 27 | from Times of India
To the Editor: The trial of treatment of mild gestational diabetes mellitus showed no difference in primary outcomes (Oct. 1 ...
Wed, Jan 27 | from New England Journal of Medicine
Researchers are testing an artificial pancreas in 23 patients in Italy, France and the U.S. Some say the technology may revolutionize the way patients manage their disease.
Wed, Jan 27 | from TheDenverChannel.com
Lexicon Pharmaceuticals, Inc. will hold a conference call on Thursday, January 28, 2010 at 11:30 am Eastern Time to discuss its recent top-line Phase 2 clinical results with LX4211, Lexicon's once-per-day, orally-delivered, small molecule drug candidate for the treatment of type 2 d...
Tue, Jan 26 | from Yahoo! Finance
Washington, Jan 26 : Better treatments for Type I diabetes may be on the anvil, thanks to a new study which improves the understanding of how insulin interacts with cells in the human body.
Mon, Jan 25 | from NewKerala.com
Jan. 25 (Bloomberg) -- Novo Nordisk A/S , the world’s largest maker of insulin, won U.S. Food and Drug Administration approval for its diabetes drug Victoza after safety concerns delayed the agency’s decision by about 10 months.
Mon, Jan 25 | from Bloomberg
Younger patients, people with type 2 diabetes, lower income earners, people prescribed more daily injections, higher-educated respondents and patients not following a healthful diet are more likely to cut back on shots, according to an Internet survey.
Mon, Jan 25 | from USA Today
New research that significantly improves our understanding of how insulin interacts with cells in the human body is published today.The study could have major implications for the development of treatments for Type I diabetes.By developing and analysing a range of super active insuli...
Mon, Jan 25 | from RedOrbit
University of York ) New research significantly improves our understanding of how insulin interacts with cells in the human body with implications for the treatments of diabetes.
Mon, Jan 25 | from EurekAlert
| 1 | CalorieLab Calorie ... |
| 2 | News-Medical.net |
| 3 | PhysOrg.com |
| 4 | Science Daily |
| 5 | RedOrbit |
| 6 | EurekAlert |
| 7 | Yahoo! Finance |
| 8 | Medical News Today |
| 9 | Journal of American... |
| 10 | USA Today |